progesic tablets 200 milligram
eli lilly and company limited - fenoprofen - tablets - 200 milligram
progesic tablets 300 milligram
dista products limited - fenoprofen calcium - tablets - 300 milligram
comfort pac with naproxen- naproxen
pd-rx pharmaceuticals, inc. - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen 500 mg - carefully consider the potential benefits and risks of naproxen tablets, usp and other treatment options before deciding to use naproxen tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). naproxen as naproxen tablets, usp is indicated: - for the relief of the signs and symptoms of rheumatoid arthritis - for the relief of the signs and symptoms of osteoarthritis - for the relief of the signs and symptoms of ankylosing spondylitis - for the relief of the signs and symptoms of juvenile arthritis - for relief of the signs and symptoms of tendonitis - for relief of the signs and symptoms of bursitis - for relief of the signs and symptoms of acute gout - for the management of pain - for the management of primary dysmenorrhea naproxen tablets, usp are contraindicated in patients with known hypersensitivity to naproxen. naproxen tablets, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type rea
phenobarbitone (noumed)
noumed pharmaceuticals limited - phenobarbital 15mg; ; ; ; - tablet - 15 mg - active: phenobarbital 15mg excipient: lactose monohydrate magnesium stearate purified talc wheat starch - phenobarbitone is indicated for use as preoperative medication to help reduce anxiety and facilitate induction of anaesthesia. phenobarbitone a long acting barbiturate is indicated as long term anticonvulsant therapy for the treatment of generalised tonic-clonic and simple partial (cortical focus) seizures. seizures (prophylaxis and treatment) of febrile seizures.
phenobarbitone (noumed)
noumed pharmaceuticals limited - phenobarbital 30mg; ; ; ; - tablet - 30 mg - active: phenobarbital 30mg excipient: lactose monohydrate magnesium stearate purified talc wheat starch - phenobarbitone is indicated for use as preoperative medication to help reduce anxiety and facilitate induction of anaesthesia. phenobarbitone a long acting barbiturate is indicated as long term anticonvulsant therapy for the treatment of generalised tonic-clonic and simple partial (cortical focus) seizures. seizures (prophylaxis and treatment) of febrile seizures.
toradol tab 10mg tablet
syntex inc. - ketorolac tromethamine - tablet - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents
toradol inj 10mg/ml liquid
syntex inc. - ketorolac tromethamine - liquid - 10mg - ketorolac tromethamine 10mg - other nonsteroidal antiimflammatory agents
etodolac- etodolac tablet, extended release
bryant ranch prepack - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 400 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac extended-release tablets are indicated: - for relief of signs and symptoms of juvenile arthritis. - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma ). etodolac extended-release tablets are contr
etodolac- etodolac tablet, extended release
lake erie medical & surgical supply dba quality care products llc - etodolac (unii: 2m36281008) (etodolac - unii:2m36281008) - etodolac 500 mg - carefully consider the potential benefits and risks of etodolac extended-release tablets and other treatment options before deciding to use etodolac extended-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). etodolac extended-release tablets are indicated: - for relief of signs and symptoms of juvenile arthritis. - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. etodolac extended-release tablets are contraindicated in patients with known hypersensitivity to etodolac. etodolac extended-release tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions and precautions, preexisting asthma ). etodolac extended-release tablets are contr
diclofenac sodium- diclofenac sodium tablet, film coated, extended release
sandoz inc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 100 mg - carefully consider the potential benefits and risks of diclofenac sodium extended-release tablets, usp and other treatment options before deciding to use diclofenac sodium extended-release tablets, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium extended-release tablets, usp are indicated: - for relief of the signs and symptoms of osteoarthritis - for relief of the signs and symptoms of rheumatoid arthritis diclofenac sodium extended-release tablets, usp is contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium extended-release tablets, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactic reactions, and precautions, preexisting asthma). diclofenac sodium extended-release